Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation

Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA.
Pflügers Archiv - European Journal of Physiology (Impact Factor: 4.1). 03/2011; 461(3):387-97. DOI: 10.1007/s00424-010-0904-3
Source: PubMed


Phosphatidylinositol-4,5-bisphosphate [PI(4,5)P(2) or PIP(2)] is a direct modulator of a diverse array of proteins in eukaryotic cells. The functional integrity of transmembrane proteins, such as ion channels and transporters, is critically dependent on specific interactions with PIP(2) and other phosphoinositides. Here, we report a novel requirement for PIP(2) in the activation of the epidermal growth factor receptor (EGFR). Down-regulation of PIP(2) levels either via pharmacological inhibition of PI kinase activity, or via manipulation of the levels of the lipid kinase PIP5K1α and the lipid phosphatase synaptojanin, reduced EGFR tyrosine phosphorylation, whereas up-regulation of PIP(2) levels via overexpression of PIP5K1α had the opposite effect. A cluster of positively charged residues in the juxtamembrane domain (basic JD) of EGFR is likely to mediate binding of EGFR to PIP(2) and PIP(2)-dependent regulation of EGFR activation. A peptide mimicking the EGFR juxtamembrane domain that was assayed by surface plasmon resonance displayed strong binding to PIP(2). Neutralization of positively charged amino acids abolished EGFR/PIP(2) interaction in the context of this peptide and down-regulated epidermal growth factor (EGF)-induced EGFR auto-phosphorylation and EGF-induced EGFR signaling to ion channels in the context of the full-length receptor. These results suggest that EGFR activation and downstream signaling depend on interactions of EGFR with PIP(2) and point to the basic JD's critical involvement in these interactions. The addition of this very different class of membrane proteins to ion channels and transporters suggests that PIP(2) may serve as a general modulator of the activity of many diverse eukaryotic transmembrane proteins through their basic JDs.

Download full-text


Available from: Anastasios Georgakopoulos
  • Source
    • "The PIP 2 molecules interacted favourably and extensively with the positively charged residues of the JM, and in particular with the R645–R647 cationic cluster, in good agreement with the experimental studies of Michailidis et al. [16]. Comparison of the interactions between the JM region and PIP 2 in the CG-MD simulations of the WT and mutant (ASN3) suggests that the mutation not only reduces PIP 2 binding but also results in destabilization of the antiparallel JM helix dimer and less tight packing of the transmembrane helices. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: The epidermal growth factor receptor (EGFR) is the best characterised member of the receptor tyrosine kinases, which play an important role in signalling across mammalian cell membranes. The EGFR juxtamembrane (JM) domain is involved in the mechanism of activation of the receptor, interacting with the anionic lipid phosphatidylinositol 4,5-bisphosphate (PIP2) in the intracellular leaflet of the cell membrane. Methods: Multiscale MD simulations were used to characterize PIP2-JM interactions. Simulations of the transmembrane helix plus JM region (TM-JM) dimer (PDB:2M20) in both PIP2-containing and PIP2-depleted lipid bilayer membranes revealed the interactions of the JM with PIP2 and other lipids. Results: PIP2 forms strong interactions with the basic residues in the R645-R647 motif of the JM domain resulting in clustering of PIP2 around the protein. This association of PIP2 and the JM domain aids stabilization of JM-A dimer away from the membrane. Mutation (R645N/R646N/R647N) or PIP2-depletion results in deformation of the JM-A dimer and changes in JM-membrane interactions. Conclusions: These simulations support the proposal that the positively charged residues at the start of the JM-A domain stabilize the JM-A helices in an orientation away from the membrane surface through binding to PIP2, thus promoting a conformation corresponding to an asymmetric (i.e. activated) kinase. General significance: This study indicates that MD simulations may be used to characterise JM/lipid interactions, thus helping to define their role in the mechanisms of receptor tyrosine kinases. This article is part of a Special Issue entitled Recent developments of molecular dynamics. (C) 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (
    Full-text · Article · Sep 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
  • Source
    • "PAO is a potent tyrosine phosphatase inhibitor (Garcia-Morales et al. 1990), and also specifically inhibits protein kinase IIa, which is responsible for maintaining the balance of PIP2 in the plasma membrane (Santos et al. 2013). PIP2 has been shown to influence the activity of the ErbB1 by binding to the intracellular juxtamembrane domain (Michailidis et al. 2011). The pleiotropic effects of this cellular effector, and the general effects of phosphatase inhibition, therefore, complicate the interpretation of these data. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We review the states of the ErbB family of receptor tyrosine kinases (RTKs), primarily the EGF receptor (EGFR, ErbB1, HER1) and the orphan receptor ErbB2 as they exist in living mammalian cells, focusing on four main aspects: (1) aggregation state and distribution in the plasma membrane; (2) conformational features of the receptors situated in the plasma membrane, compared to the crystallographic structures of the isolated extracellular domains; (3) coupling of receptor disposition on filopodia with the transduction of signaling ligand gradients; and (4) ligand-independent receptor activation by application of a magnetic field.
    Full-text · Article · Apr 2014 · Cold Spring Harbor perspectives in biology
  • Source
    • "VSPs are homologs to PTEN, an enzyme critically involved in the control of cell growth and proliferation, as well as in cell differentiation (Leslie and Downes, 2002, 2004; Bai et al., 2004; Menager et al., 2004; Walker et al., 2004; Balla et al., 2005; Leslie et al., 2007, 2008; Endersby and Baker, 2008; Ooms et al., 2009; Arendt et al., 2010; Bunney and Katan, 2010; Davidson et al., 2010; Michailidis et al., 2011). PTEN is known as a tumor suppressor – disruption of its function is among the most common causes of cancer in humans (Li et al., 1997; Teng et al., 1997; Maehama and Dixon, 1998, 1999; Leslie and Downes, 2004; Bunney and Katan, 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Ciona intestinalis voltage-sensitive phosphatase, Ci-VSP, was the first Voltage-controlled Enzyme (VEnz) proven to be under direct command of the membrane potential. The discovery of Ci-VSP conjugated voltage sensitivity and enzymatic activity in a single protein. These two facets of Ci-VSP activity have provided a unique model for studying how membrane potential is sensed by proteins and a novel mechanism for control of enzymatic activity. These facets make Ci-VSP a fascinating and versatile enzyme. Ci-VSP has a voltage sensing domain (VSD) that resembles those found in voltage-gated channels (VGC). The VSD resides in the N-terminus and is formed by four putative transmembrane segments. The fourth segment contains charged residues which are likely involved in voltage sensing. Ci-VSP produces sensing currents in response to changes in potential, within a defined range of voltages. Sensing currents are analogous to “gating” currents in VGC. As known, these latter proteins contain four VSDs which are entangled in a complex interaction with the pore domain – the effector domain in VGC. This complexity makes studying the basis of voltage sensing in VGC a difficult enterprise. In contrast, Ci-VSP is thought to be monomeric and its catalytic domain – the VSP’s effector domain – can be cleaved off without disrupting the basic electrical functioning of the VSD. For these reasons, VSPs are considered a great model for studying the activity of a VSD in isolation. Finally, VSPs are also phosphoinositide phosphatases. Phosphoinositides are signaling lipids found in eukaryotes and are involved in many processes, including modulation of VGC activity and regulation of cell proliferation. Understanding VSPs as enzymes has been the center of attention in recent years and several reviews has been dedicated to this area. Thus, this review will be focused instead on the other face of this true Janus Bifrons and recapitulate what is known about VSPs as electrically active proteins.
    Full-text · Article · Sep 2012 · Frontiers in Pharmacology
Show more